Cancer Genetics and Epigenetics, 2025, Vol.13, No.1, 1-10 http://medscipublisher.com/index.php/cge 8 Chen Z.S., Guo X.Y., Tao R., Huyghe J.R., Law P., Fernández-Rozadilla C., Ping J., Jia G., Long J., Li C., Shen Q., Xie Y., Timofeeva, M., Thomas M., Schmit S., Díez-Obrero V., Devall M., Moratalla-Navarro F., Fernandez-Tajes J., Palles C., Sherwood K., Briggs S., Svinti V., Donnelly K., Farrington S., Blackmur J., Vaughan-Shaw P., Shu X., Lu Y., Broderick P., Studd J., Harrison T., Conti D., Schumacher F., Melas M., Rennert G., Obón-Santacana M., Martín-Sánchez V., Oh J., Kim J., Jee S., Jung K., Kweon S., Shin M., Shin A., Ahn Y., Kim D., Oze I., Wen W., Matsuo K., Matsuda K., Tanikawa C., Ren Z., Gao Y., Jia W., Hopper J., Jenkins M., Win A., Pai R., Figueiredo J., Haile R., Gallinger S., Woods M., Newcomb P., Duggan D., Cheadle J., Kaplan R., Kerr R., Kerr D., Kirac I., Böhm J., Mecklin J., Jousilahti P., Knekt P., Aaltonen L., Rissanen H., Pukkala E., Eriksson J., Cajuso T., Hänninen U., Kondelin J., Palin K., Tanskanen T., Renkonen-Sinisalo L., Männistö S., Albanes D., Weinstein S., Ruiz-Narvaez E., Palmer J., Buchanan D., Platz E., Visvanathan K., Ulrich C., Siegel E., Brezina S., Gsur A., Campbell P., Chang-Claude J., Hoffmeister M., Brenner H., Slattery M., Potter J., Tsilidis K., Schulze M., Gunter M., Murphy N., Castells A., Castellví-Bel S., Moreira L., Arndt V., Shcherbina A., Bishop D., Giles G., Southey M., Idos G., McDonnell K., Abu-Ful Z., Greenson J., Shulman K., Lejbkowicz F., Offit K., Su Y., Steinfelder R., Keku T., Van Guelpen B., Hudson T., Hampel H., Pearlman R., Berndt S., Hayes R., Martínez M., Thomas S., Pharoah P., Larsson S., Yen Y., Lenz H., White E., Li L., Doheny K., Pugh E., Shelford T., Chan A., Cruz-Correa M., Lindblom A., Hunter D., Joshi A., Schafmayer C., Scacheri P., Kundaje A., Schoen R., Hampe J., Stadler Z., Vodicka P., Vodickova L., Vymetálková V., Edlund C., Gauderman W., Shibata D., Toland A., Markowitz S., Kim A., Chanock S., Van Duijnhoven F., Feskens E., Sakoda L., Gago-Domínguez M., Wolk A., Pardini B., FitzGerald L., Lee S., Ogino S., Bien S., Kooperberg C., Li C., Lin Y., Prentice R., Qu C., Bézieau S., Yamaji T., Sawada N., Iwasaki M., Marchand L., Wu A., Qu C., McNeil C., Coetzee G., Hayward C., Deary I., Harris S.E., Theodoratou E., Reid S., Walker M., Ooi L., Lau K., Zhao H., Hsu L., Cai Q., Dunlop M., Gruber S.B., Houlston R.S., Moreno V., Casey G., Peters U., Tomlinson I., and Zheng W., 2024, Fine-mapping analysis including over 254 000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes, Nature Communications, 15(1): 3557. https://doi.org/10.1038/s41467-024-47399-x Chen Z.S., Song W., Shu X., Wen W., Devall M., Dampier C., Moratalla-Navarro F., Cai Q., Long J., Van Kaer L., Wu L., Huyghe J., Thomas M., Hsu L., Woods M., Albanes D., Buchanan D., Gsur A., Hoffmeister M., Vodicka P., Wolk A., Marchand L., Wu A., Phipps A.I., Moreno V., Ulrike P., Zheng W., Casey G., and Guo X.Y., 2023, Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation, Journal of the National Cancer Institute, 116(1): 127-137. https://doi.org/10.1093/jnci/djad178 Chubb D., Broderick P., Frampton M., Kinnersley B., Sherborne A., Penegar S., Lloyd, A., Ma Y., Dobbins S., and Houlston R., 2015, Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing, Journal of Clinical Oncology, 33(5): 426-432. https://doi.org/10.1200/JCO.2014.56.5689 Dueñas N., Klinkhammer H., Bonifaci N., Spier I., Mayr A., Hassanin E., Díez-Villanueva A., Moreno V., Pineda M., Maj C., Capellá G., Aretz S., and Brunet J., 2023, Ability of a polygenic risk score to refine colorectal cancer risk in lynch syndrome, Journal of Medical Genetics, 60: 1044-1051. https://doi.org/10.1136/jmg-2023-109344 Frampton M., Law P., Litchfield K., Morris E., Kerr D., Turnbull C., Turnbull C., Tomlinson I., and Houlston R., 2016, Implications of polygenic risk for personalised colorectal cancer screening, Annals of Oncology, 27(3): 429-434. https://doi.org/10.1093/annonc/mdv540 Guo F., Edelmann D., Cardoso R., Chen X., Carr P., Chang-Claude J., Hoffmeister M., and Brenner H., 2022, Polygenic risk score for defining personalized surveillance intervals after adenoma detection and removal at colonoscopy, Clinical Gastroenterology and Hepatology, 21(1): 210-219. https://doi.org/10.1016/j.cgh.2022.03.013 Guo F., Weigl K., Carr P.R., Heisser T., Jansen L., Knebel P., Chang-Claude J., Hoffmeister M., and Brenner H., 2020, Use of polygenic risk scores to select screening intervals after negative findings from colonoscopy, Clinical Gastroenterology and Hepatology, 18(12): 2742-2751. https://doi.org/10.1016/j.cgh.2020.04.077 Guo X., Lin W., Wen W., Huyghe J., Bien S., Cai Q., Harrison T., Chen Z., Qu C., Bao J., Long J., Yuan Y., Wang F., Bai M., Abecasis G., Albanes D., Berndt S., Bézieau S., Bishop D., Brenner H., Buch S., Burnett-Hartman A., Campbell P., Castellví-Bel S., Chan A., Chan A., Chang-Claude J., Chanock S., Cho S., Conti D., Chapelle A., Feskens E., Gallinger S., Giles G., Giles G., Goodman P., Gsur A., Guinter M., Gunter M., Hampe J., Hampel H., Hayes R., Hoffmeister M., Kampman E., Kang H., Keku T., Kim H., Marchand L., Lee S., Li C., Li L., Lindblom A., Lindblom A., Lindor N., Milne R., Milne R., Moreno V., Murphy N., Newcomb P., Newcomb P., Nickerson D., Offit K., Offit K., Pearlman R., Pharoah P., Platz E., Potter J., Rennert G., Sakoda L., Sakoda L., Schafmayer C., Schmit S., Schoen R., Schumacher F., Slattery M., Su Y., Tangen C., Ulrich C., Duijnhoven F., Guelpen B., Visvanathan K., Vodicka P., Vodickova L., Vymetálková V., Wang X., White E., White E., Wolk A., Woods M., Casey G., Hsu L., Jenkins M., Gruber S., Peters U., Peters U., and Zheng W., 2020, Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125 478 subjects, Gastroenterology, 160(4): 1164-1178. https://doi.org/10.1053/j.gastro.2020.08.062 Hassanin E., Spier I., Bobbili D., Aldisi R., Klinkhammer H., David F., Dueñas N., Hüneburg R., Perne C., Brunet J., Capellá G., Nöthen M., Forstner A., Mayr A., Krawitz P., May P., Aretz S., and Maj C., 2022, Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence, BMC Medical Genomics, 16(1): 42. https://doi.org/10.1186/s12920-023-01469-z Houlston R., and Tomlinson I., 2001, Polymorphisms and colorectal tumor risk, Gastroenterology, 121(2): 282-301. https://doi.org/10.1053/GAST.2001.26265
RkJQdWJsaXNoZXIy MjQ4ODYzNA==